The patient consented to genetic testing for a VHL variant alongside the next-generation panel testing for mutations in a series of other genes associated with pheochromocytoma (i.e., EPAS1, FH, IDH1, KIF1B, KIT, MAX, MDH2, NF1, NF2, PDGFRA, RET, SDHA, SDHAF2, SDHB, SDHC, SDHD, and TMEM127). Here, VHL is linked to hereditary pheochromocytoma-paraganglioma.